Literature DB >> 11687192

Directly observed therapy for treating tuberculosis.

J Volmink1, P Garner.   

Abstract

BACKGROUND: Up to half the people with tuberculosis do not complete their treatment. Strategies to improve adherence to diagnostic and treatment regimens are therefore important.
OBJECTIVES: To assess the effects of directly observed therapy by an appointed agent (health worker, community volunteer, or family member) on cure and treatment completion in people on treatment for tuberculosis. SEARCH STRATEGY: We searched The Cochrane Controlled Trials Register, the Cochrane Infectious Diseases Group specialized trials register, MEDLINE, EMBASE, LILACS, and reference lists of articles. We also contacted experts in the field. SELECTION CRITERIA: Randomized and quasi-randomized trials of direct observation of tablet swallowing compared with self treatment for tuberculosis. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and extracted data. MAIN
RESULTS: Four studies (n = 1603 participants) included. There was no difference detected between direct observation and self treatment for cure (Relative Risk [RR] 1.06, 95% confidence interval [CI] 0.98 to 1.14); and for cure plus treatment completion (RR 1.06, 95% CI 1.00 to 1.13). A stratified analysis by the appointed agent (health professional, lay health worker, or family/community member) did not reveal any important differences. One study conducted in an optimal setting in which patients were given a choice of supervisor did show modest benefit: cure (RR 1.13, 95% CI 1.04 to 1.24); cure plus treatment completion (RR 1.11, 95% CI 1.03 to 1.18). REVIEWER'S
CONCLUSIONS: Randomized trials provide no evidence that directly observed therapy in low and middle income country settings improves cure or treatment completion rates in patients with tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687192     DOI: 10.1002/14651858.CD003343

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  13 in total

Review 1.  An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors:  Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

Review 2.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

3.  The Use of Research Evidence in Two International Organizations' Recommendations about Health Systems.

Authors:  Steven J Hoffman; John N Lavis; Sara Bennett
Journal:  Healthc Policy       Date:  2009-08

4.  Effect of a hospital-based case management approach on treatment outcome of patients with tuberculosis.

Authors:  Rong-Luh Lin; Fung-J Lin; Chien-Liang Wu; Ming-Jen Peng; Pei-Jan Chen; Hsu-Tah Kuo
Journal:  J Formos Med Assoc       Date:  2006-08       Impact factor: 3.282

5.  DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008.

Authors:  Y-F Yen; T C Rodwell; M-Y Yen; H-C Shih; B-S Hu; L-H Li; Y-H Shie; P Chuang; R S Garfein
Journal:  Int J Tuberc Lung Dis       Date:  2012-02       Impact factor: 2.373

6.  Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

Authors:  Patrick K Moonan; Teresa N Quitugua; Janice M Pogoda; Gary Woo; Gerry Drewyer; Behzad Sahbazian; Denise Dunbar; Kenneth C Jost; Charles Wallace; Stephen E Weis
Journal:  BMC Public Health       Date:  2011-01-07       Impact factor: 3.295

7.  Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia.

Authors:  Estifanos Biru Shargie; Bernt Lindtjørn
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

8.  DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: a retrospective trend analysis.

Authors:  Estifanos B Shargie; Bernt Lindtjørn
Journal:  BMC Public Health       Date:  2005-06-06       Impact factor: 3.295

Review 9.  Directly observed therapy for treating tuberculosis.

Authors:  Jamlick Karumbi; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

10.  Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives.

Authors:  Geetika Verma; Ross E G Upshur; Elizabeth Rea; Solomon R Benatar
Journal:  BMC Med Ethics       Date:  2004-03-12       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.